Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

GLP-1RAs may cause hair loss but could also help regrow hair in some cases.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Metformin can help diagnose and treat high testosterone levels in women, often due to insulin resistance rather than a tumor.

The hydrogel significantly improves healing in diabetic wounds.

Lean and obese women with PCOS have similar levels of insulin resistance, indicating it's a core aspect of the condition.

Early recognition and comprehensive management of PCOS can prevent long-term health issues.

Early recognition and comprehensive management of PCOS can prevent long-term health issues.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Women with both type 2 diabetes and PCOS have worse metabolic issues but milder reproductive symptoms after sleeve gastrectomy.

A man with itchy skin lesions and weight loss was diagnosed with a rare skin condition linked to a pancreatic tumor.

Semaglutide helps obese PCOS patients lose weight and improve health.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Higher blood sugar levels may lead to more severe hair loss in women.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.